Optomed PLC (HE:OPTOMED) — Stock Price
Optomed PLC (HE:OPTOMED) is currently trading at €1.75 EUR, up 6.43% today. Over the past 52 weeks, shares have ranged between €1.40 and €4.13. This page tracks Optomed PLC's live share price on the HE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Optomed PLC (OPTOMED) total market value.
Optomed PLC (OPTOMED) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Optomed PLC's daily closing share price and trading volume on the HE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Optomed PLC Income Statement — Revenue, Profit & Earnings by Year
Optomed PLC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €15.04 Million | €15.10 Million | €14.66 Million | €14.85 Million | €13.01 Million |
| Cost of Revenue | €5.37 Million | €4.86 Million | €5.45 Million | €5.10 Million | €4.21 Million |
| Gross Profit | €9.67 Million | €10.24 Million | €9.21 Million | €9.75 Million | €8.80 Million |
| Research & Development | €297.00K | €2.95 Million | €361.00K | €412.00K | €276.00K |
| SG&A | €3.20 Million | €2.51 Million | €765.00K | €866.00K | €714.00K |
| Total Operating Expenses | €15.62 Million | €14.22 Million | €13.88 Million | €14.12 Million | €11.54 Million |
| Operating Income | €-5.96 Million | €-3.97 Million | €-4.67 Million | €-4.37 Million | €-2.75 Million |
| EBITDA | €-2.24 Million | €-1.30 Million | €-4.23 Million | €-2.97 Million | €-281.00K |
| EBIT | €-4.74 Million | €-3.50 Million | €-5.44 Million | €-4.23 Million | €-2.45 Million |
| Interest Expense | €776.00K | €288.00K | €268.00K | €165.00K | €171.00K |
| Income Before Tax | €-5.52 Million | €-4.52 Million | €-5.55 Million | €-4.33 Million | €-3.25 Million |
| Income Tax Expense | €-66.00K | €-78.00K | €-79.00K | €-78.00K | €-70.00K |
| Net Income | €-5.45 Million | €-4.44 Million | €-5.47 Million | €-4.25 Million | €-3.18 Million |
Optomed PLC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Optomed PLC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €31.78 Million | €29.08 Million | €31.30 Million | €29.00 Million | €31.07 Million |
| Total Current Assets | €15.70 Million | €13.13 Million | €16.09 Million | €14.37 Million | €16.78 Million |
| Cash & Equivalents | €10.47 Million | €7.12 Million | €8.52 Million | €6.80 Million | €10.61 Million |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | €3.27 Million | €3.19 Million | €4.57 Million | €4.63 Million | €3.64 Million |
| Inventory | €1.96 Million | €2.82 Million | €3.00 Million | €2.94 Million | €2.54 Million |
| Property, Plant & Equipment | €2.11 Million | €2.18 Million | €2.30 Million | €1.64 Million | €1.52 Million |
| Goodwill | €4.26 Million | €4.26 Million | €4.26 Million | €4.26 Million | €4.26 Million |
| Total Liabilities | €8.14 Million | €8.72 Million | €10.96 Million | €11.95 Million | €11.00 Million |
| Total Current Liabilities | €5.58 Million | €5.05 Million | €5.23 Million | €4.91 Million | €3.49 Million |
| Long-term Debt | €1.31 Million | €2.36 Million | €4.29 Million | €5.75 Million | €6.19 Million |
| Net Debt | €-6.66 Million | €-2.26 Million | €-1.78 Million | €1.43 Million | €-2.88 Million |
| Total Stockholder Equity | €23.64 Million | €20.36 Million | €20.34 Million | €17.05 Million | €20.07 Million |
| Retained Earnings | €-36.56 Million | €-31.49 Million | €-27.19 Million | €-21.97 Million | €-18.15 Million |
Optomed PLC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Optomed PLC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-1.60 Million | €-615.00K | €-2.37 Million | €-2.94 Million | €-2.80 Million |
| Capital Expenditures | €2.12 Million | €2.41 Million | €3.03 Million | €2.57 Million | €1.82 Million |
| Free Cash Flow | €-3.71 Million | €-3.03 Million | €-5.40 Million | €-5.51 Million | €-4.62 Million |
| Investing Cash Flow | €-2.12 Million | €-2.41 Million | €-3.03 Million | €-2.57 Million | €-1.82 Million |
| Financing Cash Flow | €7.08 Million | €1.61 Million | €7.00 Million | €1.64 Million | €-3.70 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | €137.00K | €253.00K | €340.00K | €406.00K |
| Depreciation | €2.50 Million | €2.19 Million | €3.15 Million | €2.69 Million | €2.17 Million |
| Change in Cash | €3.35 Million | €-1.41 Million | €1.72 Million | €-3.80 Million | €-8.26 Million |
Optomed PLC Earnings History — EPS Actual vs. Analyst Estimates
Track Optomed PLC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 04, 2026 | — | — | — |
| Feb 11, 2026 | — | — | — |
| Nov 06, 2025 | -0.08 | -0.07 | -14.29% |
| Aug 07, 2025 | -0.08 | -0.07 | -14.29% |
| May 06, 2025 | -0.08 | -0.07 | -14.29% |
| Feb 13, 2025 | -0.04 | -0.01 | -300.00% |
| Nov 07, 2024 | -0.09 | -0.09 | +0.00% |
| Aug 08, 2024 | -0.10 | -0.04 | -150.00% |